| Communication on Medicines Registration Renewals Implementation Framework | Communication to industry | 24/11/2022 | 2 | Biological Medicines, General ECTD & human medicines, Quality, Veterinary medicines | pdf | Download | communication-to-industry | biological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines quality veterinary-medicines |
| Retention Fee Notification – 9 June 2022 | Communication to industry | 24/06/2022 | 1 | Biological Medicines, General ECTD & human medicines, Inspectorate and good manufacturing practices, Medical Devices | pdf | Download | communication-to-industry | biological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines inspectorate-and-good-manufacturing-practices medical-devices |
| Submission of Post-Importation Testing Exemption requests for Biological and Biosimilar Medicines | Communication to industry | 24/03/2022 | 1 | Biological Medicines, Inspectorate and good manufacturing practices | pdf | Download | communication-to-industry | biological-medicines-evaluation-and-research inspectorate-and-good-manufacturing-practices |
| 9.126 | Reflection document on regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2 | Communication to industry | 20/05/2021 | 1 | Biological Medicines | | Download | communication-to-industry | biological-medicines-evaluation-and-research |
